|
VPS53 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.988000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.702600E-01 |
| Normal-vs-Stage2 |
6.994200E-01 |
| Normal-vs-Stage3 |
1.032250E-01 |
| Normal-vs-Stage4 |
3.958700E-04 |
| Stage1-vs-Stage2 |
7.983000E-01 |
| Stage1-vs-Stage3 |
1.343950E-01 |
| Stage1-vs-Stage4 |
8.991600E-04 |
| Stage2-vs-Stage3 |
4.004600E-01 |
| Stage2-vs-Stage4 |
1.905710E-02 |
| Stage3-vs-Stage4 |
1.273960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.277400E-01 |
| Normal-vs-AfricanAmerican |
3.566600E-01 |
| Normal-vs-Asian |
3.853400E-01 |
| Caucasian-vs-AfricanAmerican |
5.248200E-01 |
| Caucasian-vs-Asian |
6.287800E-01 |
| AfricanAmerican-vs-Asian |
8.001200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.509400E-01 |
| Normal-vs-Female |
3.729000E-01 |
| Male-vs-Female |
4.752300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.217400E-01 |
| Normal-vs-Extreme_Weight |
1.572160E-01 |
| Normal-vs-Obese |
8.979200E-01 |
| Normal-vs-Extreme_Obese |
8.895800E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.450600E-01 |
| Normal_Weight-vs-Obese |
2.649400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.133200E-01 |
| Extreme_Weight-vs-Obese |
2.201400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.989000E-01 |
| Obese-vs-Extreme_Obese |
9.241400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.135400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.234200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.787640E-01 |
| Normal-vs-Age(81-100Yrs) |
1.962520E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.151000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.885800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.077900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.813700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.274220E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.408300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.237400E-01 |
| Normal-VS-Type2 PRCC |
1.878410E-02 |
| Normal-VS-KIRP CIMP |
7.686800E-01 |
| Normal-VS-Unclassified PRCC |
3.235600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.422020E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.829000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.737400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.342400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.216700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.187400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.233860E-02 |
| Normal-vs-N1 |
1.390420E-01 |
| Normal-vs-N2 |
7.542800E-03 |
| N0-vs-N1 |
5.303000E-01 |
| N0-vs-N2 |
2.542600E-01 |
| N1-vs-N2 |
1.924150E-01 |
|
|
